Managing Partner & Chairman

Denis Lucquin is a Managing Partner and Chairman who specialises in life sciences, and also, more recently, in cleantech investments. He joined Sofinnova in 1991. Denis began his career in academic research. For five years, he was in charge of the technology transfer department at the Institut National de la Recherche Agronomique (INRA), France's agricultural research institute. In 1989, he joined the venture capital industry as director of investments at Innolion (Crédit Lyonnais).
He carried out many investments in Europe such as Nicox, Oxford Glycosciences, Oxford Molecular, PPL Therapeutics, Conjuchem, Exonhit, IDM, Innate Pharma and Ablynx (all of which successfully went public) and Crop Design, Cerenis, Novexel and Noxxon. He actively supports all of these companies and acts or as acted as a board member for most of them. He is also a founder of Association France Biotech. He is a graduate in engineering from Ecole Polytechnique and Ecole du Génie Rural des Eaux et Forêts. He also has a degree in Innovation Management from the Université de Paris-Dauphine.